Safety of surgery for managing hyperthyroidism in patients with or without preoperative euthyroidism: A systematic review and meta-analysis.

IF 3.7 3区 医学 Q2 Medicine
Eddy P Lincango, Luis A Figueroa, Cristina Arias Cortez, Doménica Herrera Hernandez, Emily Rivadeneira Cabezas, Francisco Rivadeneira Proaño, Pedro Isaac Torres Balarezo, Domenica Brito, Luis Serrano, Adela Casas-Melley, Dustin Huynh, Alvaro Sanabria, Bradley Johnson, Benjamin James, Lilah Morris-Wiseman, Julie A Sosa, Benzon Dy, Minerva A Romero Arenas, Carmen C Solorzano, Sophie Dream, Juan P Brito
{"title":"Safety of surgery for managing hyperthyroidism in patients with or without preoperative euthyroidism: A systematic review and meta-analysis.","authors":"Eddy P Lincango, Luis A Figueroa, Cristina Arias Cortez, Doménica Herrera Hernandez, Emily Rivadeneira Cabezas, Francisco Rivadeneira Proaño, Pedro Isaac Torres Balarezo, Domenica Brito, Luis Serrano, Adela Casas-Melley, Dustin Huynh, Alvaro Sanabria, Bradley Johnson, Benjamin James, Lilah Morris-Wiseman, Julie A Sosa, Benzon Dy, Minerva A Romero Arenas, Carmen C Solorzano, Sophie Dream, Juan P Brito","doi":"10.1007/s12020-025-04340-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Guidelines recommend achieving normal thyroid function (euthyroidism) before thyroid surgery to treat hyperthyroidism due to concerns about uncontrolled thyroid hormone release during surgery. However, achieving euthyroidism before surgery may not always be possible. We aim to evaluate postoperative outcomes of hyperthyroid patients who were euthyroid versus those who were not before thyroid surgery.</p><p><strong>Methods: </strong>We searched Medline, Embase, Scopus, and Cochrane from inception to July 2023 to identify comparative studies on hyperthyroid patients who were euthyroid or hyperthyroid (elevated thyroxine levels) before surgery. We evaluated post-surgical complication rates in each group. A random-effects model was used to consolidate dichotomous variables with odds ratios (OR) and continuous variables with mean differences (MD), both with 95% confidence intervals (95% CI). The risk of bias was assessed using the Newcastle-Ottawa Scale.</p><p><strong>Results: </strong>We included eight retrospective cohort studies involving 1336 patients, of whom 33.6% (n = 449) were biochemically hyperthyroid at the time of thyroidectomy. Most of these patients were female (67.2%, n = 899), with an average age (SD) of 38.73 ± 2.80 years, and had Graves' Disease (96%). The mean (SD) preoperative TSH was 0.28 ± 0.10 mIU/L, FT4 was 3.33 ± 0.64 ng/dL, and FT3 was 67.65 ± 22.41 pg/mL. No significant differences were observed in postoperative complications between preoperatively euthyroid and hyperthyroid patients. This includes temporary hypocalcemia (OR: 0.50, 95% CI: 0.20-1.29, I<sup>2</sup>: 42.7%, n = 521), permanent hypocalcemia (OR: 0.46, 95% CI: 0.11-1.96, I<sup>2</sup>: 0.0%, n = 727), temporary hoarseness (OR: 1.46, 95% CI: 0.59-3.64, I<sup>2</sup>: 0.0%, n = 541), permanent hoarseness (OR: 0.74, 95% CI: 0.13-4.34, I<sup>2</sup>: 0.0%, n = 727), bleeding risks (OR: 0.27, 95% CI: 0.06-1.28, I<sup>2</sup>: 0.0%, n = 541), length of hospital stay (MD: 0.0, 95% CI: -0.2-0.2, n = 379), and operative time (MD: -5.6, 95% CI: -15.4-4.3, n = 674). There was one case of thyroid storm after surgery in the hyperthyroid group, with no mortalities reported. The risk of bias was moderate in six studies and high in two.</p><p><strong>Conclusions: </strong>Low-to-moderate quality evidence suggests preoperatively euthyroid patients undergoing total thyroidectomy have lower risks of hypocalcemia, hoarseness, and hematoma than hyperthyroid patients, though differences are not statistically significant. These findings can guide recommendations for hyperthyroidism management and help clinicians weigh surgical risks and benefits for hyperthyroid patients.</p>","PeriodicalId":11572,"journal":{"name":"Endocrine","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12020-025-04340-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Guidelines recommend achieving normal thyroid function (euthyroidism) before thyroid surgery to treat hyperthyroidism due to concerns about uncontrolled thyroid hormone release during surgery. However, achieving euthyroidism before surgery may not always be possible. We aim to evaluate postoperative outcomes of hyperthyroid patients who were euthyroid versus those who were not before thyroid surgery.

Methods: We searched Medline, Embase, Scopus, and Cochrane from inception to July 2023 to identify comparative studies on hyperthyroid patients who were euthyroid or hyperthyroid (elevated thyroxine levels) before surgery. We evaluated post-surgical complication rates in each group. A random-effects model was used to consolidate dichotomous variables with odds ratios (OR) and continuous variables with mean differences (MD), both with 95% confidence intervals (95% CI). The risk of bias was assessed using the Newcastle-Ottawa Scale.

Results: We included eight retrospective cohort studies involving 1336 patients, of whom 33.6% (n = 449) were biochemically hyperthyroid at the time of thyroidectomy. Most of these patients were female (67.2%, n = 899), with an average age (SD) of 38.73 ± 2.80 years, and had Graves' Disease (96%). The mean (SD) preoperative TSH was 0.28 ± 0.10 mIU/L, FT4 was 3.33 ± 0.64 ng/dL, and FT3 was 67.65 ± 22.41 pg/mL. No significant differences were observed in postoperative complications between preoperatively euthyroid and hyperthyroid patients. This includes temporary hypocalcemia (OR: 0.50, 95% CI: 0.20-1.29, I2: 42.7%, n = 521), permanent hypocalcemia (OR: 0.46, 95% CI: 0.11-1.96, I2: 0.0%, n = 727), temporary hoarseness (OR: 1.46, 95% CI: 0.59-3.64, I2: 0.0%, n = 541), permanent hoarseness (OR: 0.74, 95% CI: 0.13-4.34, I2: 0.0%, n = 727), bleeding risks (OR: 0.27, 95% CI: 0.06-1.28, I2: 0.0%, n = 541), length of hospital stay (MD: 0.0, 95% CI: -0.2-0.2, n = 379), and operative time (MD: -5.6, 95% CI: -15.4-4.3, n = 674). There was one case of thyroid storm after surgery in the hyperthyroid group, with no mortalities reported. The risk of bias was moderate in six studies and high in two.

Conclusions: Low-to-moderate quality evidence suggests preoperatively euthyroid patients undergoing total thyroidectomy have lower risks of hypocalcemia, hoarseness, and hematoma than hyperthyroid patients, though differences are not statistically significant. These findings can guide recommendations for hyperthyroidism management and help clinicians weigh surgical risks and benefits for hyperthyroid patients.

术前有或无甲状腺功能亢进患者手术治疗甲状腺功能亢进的安全性:一项系统综述和荟萃分析
背景:由于担心手术期间甲状腺激素释放不受控制,指南建议在甲状腺手术前实现正常的甲状腺功能(甲状腺功能亢进)来治疗甲状腺功能亢进。然而,在手术前实现甲状腺功能亢进并不总是可能的。我们的目的是评估甲状腺功能正常的甲亢患者与非甲亢患者在甲状腺手术前的术后结果。方法:我们检索Medline, Embase, Scopus和Cochrane从成立到2023年7月,以确定术前甲状腺功能正常或甲状腺功能亢进(甲状腺素水平升高)的甲状腺功能亢进患者的比较研究。我们评估各组术后并发症发生率。采用随机效应模型合并具有优势比(OR)的二分类变量和具有平均差异(MD)的连续变量,两者均有95%置信区间(95% CI)。偏倚风险采用纽卡斯尔-渥太华量表进行评估。结果:我们纳入了8项回顾性队列研究,涉及1336例患者,其中33.6% (n = 449)在甲状腺切除术时存在生化性甲状腺功能亢进。患者以女性居多(67.2%,n = 899),平均年龄(SD) 38.73±2.80岁,患有Graves病(96%)。术前TSH平均值(SD)为0.28±0.10 mIU/L, FT4平均值为3.33±0.64 ng/dL, FT3平均值为67.65±22.41 pg/mL。术前甲状腺功能正常与甲状腺功能亢进患者术后并发症无显著差异。这包括临时低钙血症(OR: 0.50, 95% CI: 0.20—-1.29,I2: 42.7%, n = 521),永久性的低钙血症(OR: 0.46, 95% CI: 0.11—-1.96,I2: 0.0%, n = 727),临时嘶哑(OR: 1.46, 95% CI: 0.59—-3.64,I2: 0.0%, n = 541),永久嘶哑(OR: 0.74, 95% CI: 0.13—-4.34,I2: 0.0%, n = 727),出血风险(OR: 0.27, 95% CI: 0.06—-1.28,I2: 0.0%, n = 541),住院时间(MD: 0.0, 95%置信区间CI: -0.2 - -0.2, n = 379)、和手术时间(MD: -5.6, 95%置信区间CI: -15.4 - -4.3, n = 674)。甲亢组术后出现甲状腺风暴1例,无死亡报告。6项研究的偏倚风险为中等,2项研究的偏倚风险为高。结论:低到中等质量的证据表明,术前甲状腺功能正常的患者行甲状腺全切除术后发生低钙、声音嘶哑和血肿的风险低于甲状腺功能亢进患者,但差异无统计学意义。这些发现可以指导甲状腺功能亢进的治疗建议,并帮助临床医生权衡甲状腺功能亢进患者的手术风险和益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endocrine
Endocrine 医学-内分泌学与代谢
CiteScore
6.40
自引率
5.40%
发文量
0
期刊介绍: Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology. Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted. Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信